Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Share-based Compensation (2021 - 2025)

P3 Health Partners' Share-based Compensation history spans 5 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 52.43% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $5.6 million, down 2.97%, while the annual FY2025 figure was $5.6 million, 2.97% down from the prior year.
  • Share-based Compensation reached $1.1 million in Q4 2025 per PIIIW's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $11.7 million in Q1 2022 to a low of $355093.0 in Q3 2021.
  • Average Share-based Compensation over 5 years is $2.0 million, with a median of $1.5 million recorded in 2024.
  • Peak YoY movement for Share-based Compensation: surged 2443.02% in 2022, then plummeted 91.66% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $2.3 million in 2021, then dropped by 5.54% to $2.2 million in 2022, then decreased by 21.57% to $1.7 million in 2023, then crashed by 58.08% to $721000.0 in 2024, then surged by 52.43% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Share-based Compensation are $1.1 million (Q4 2025), $1.2 million (Q3 2025), and $1.5 million (Q2 2025).